Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...

Oral Drug Delivery Systems: Continuous-Release Systems

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Measuring Critical Care Pharmacist Value: A Scoping Review of the Effect of Critical Care Pharmacist Activities on Clinically Relevant Outcomes.

Journal of the American College of Clinical Pharmacy : JACCP·2026

Same author

WNT Oncogenic Transcription Requires MYC Suppression of Lysosomal Activity and EPCAM Stabilization in Gastric Tumors.

Gastroenterology·2024

Same author

Decoding YAP dependent transcription in the liver.

Nucleic acids research·2022

Same author

Editor's Note: Peptide Aptamers Targeting Mutant p53 Induce Apoptosis in Tumor Cells.

Cancer research·2022

Same author

Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis.

Life science alliance·2022

Same author

Incidence of Hypotension Associated With Two Different Vasopressin Discontinuation Strategies in the Recovery Phase of Septic Shock.

Journal of pharmacy practice·2022

Search research articles

Related Experiment Video

Updated: May 18, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Chronotherapeutic drug delivery.

Paul Librodo¹, Mitchell Buckley, Marilyn Luk

¹Department of Pharmacy, Banner Good Samaritan Medical Center, Phoenix, Arizona 85006, USA. paul.alcantaralibrodo@bannerhealth.com

Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society

|September 8, 2012

Summary

Chronotherapy aligns cancer drug delivery with the body's natural circadian rhythms. This approach improves cancer patient outcomes and reduces harmful side effects from treatment.

More Related Videos

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice

Published on: October 3, 2011

Related Experiment Videos

Last Updated: May 18, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice

Published on: October 3, 2011

Area of Science:

* Physiology and chronobiology
* Oncology and pharmacology

Background:

* Living organisms exhibit daily fluctuations in physiological processes, known as circadian rhythms.
* These rhythms influence hormonal secretion, metabolism, heart rate, and renal output.
* Circadian rhythms impact the body's response to medical treatments.

Purpose of the Study:

* To review the role of chronotherapy in cancer treatment.
* To explore how coordinating drug delivery with circadian rhythms can improve patient outcomes.
* To highlight the potential of chronotherapy in enhancing quality of life and survival rates for cancer patients.

Main Methods:

* Literature review of existing studies on chronotherapy and cancer treatment.
* Analysis of how circadian rhythms affect drug metabolism and toxicity.
* Examination of clinical data on chronotherapy's impact on cancer patient outcomes.

Main Results:

* Chronotherapy can significantly enhance the effectiveness of cancer medications.
* Timing drug delivery according to circadian rhythms can reduce severe side effects.
* Cancer is identified as a chronotherapeutic disorder, responsive to timed treatments.

Conclusions:

* Chronotherapy offers a promising strategy to improve the quality of life for oncology patients.
* Integrating chronotherapy into cancer treatment protocols can potentially increase survival rates.
* Further research and clinical application of chronotherapy are warranted in oncology.